In this study, we explored whether hyperthermia could enhance the anti-tumour effect of the HSP90 inhibitor 17-DMAG in HCC, and demonstrated that the increased therapeutic benefit of this new strategy in HCC. This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.